Source comparison
Effectiveness Comparison
Clinical evidence for both peptides remains limited to animal studies, case series, and small observational trials, with no head-to-head comparative studies published in peer-reviewed literature[10,11]. BPC-157 demonstrated significant gastric ulcer healing in
This comparison does not assign a generated winner or score.
- Clinical evidence for both peptides remains limited to animal studies, case series, and small observational trials, with no head-to-head comparative studies published in peer-reviewed literature[10,11]. BPC-157 demonstrated significant gastric ulcer healing in a rat model study (n=48), with complete ulcer resolution in 87% of treated animals versus 23% in controls after 14 days of treatment at 10 μg/kg daily[19]. Tendon healing studies showed 65% improvement in tensile strength compared to controls, with histological evidence of enhanced collagen organization and reduced inflammatory markers[20].
- TB-500 effectiveness data comes primarily from wound healing and cardiac injury models, where the peptide demonstrated 42% reduction in infarct size following myocardial infarction in mice treated with 6 mg/kg twice weekly for 4 weeks[21]. Dermal wound healing studies reported 28% faster wound closure rates and 35% increased neovascularization compared to saline controls[18]. A small case series (n=12) of athletes with muscle injuries reported subjective improvement in 75% of participants receiving TB-500 at 2.5 mg twice weekly, though this study lacked proper controls and blinding[22].
- Gastric ulcer healing
- 87% complete resolution (rat study)
- No specific data
- Tendon repair
- 65% tensile strength improvement
- Limited data
- Wound closure
- 40-50% faster (animal models)
- 28% faster closure
- Cardiac protection
- 42% infarct size reduction
- Human clinical trials
- None published
- Case report outcomes
- Variable, uncontrolled
- 75% subjective improvement (n=12)
- The absence of randomized controlled trials in humans represents a critical limitation for both peptides, with effectiveness claims based primarily on extrapolation from animal studies and anecdotal reports from clinical practice[23].